Clinical–imaging–pathological correlation in pulmonary hypertension associated with left heart disease

Pulmonary hypertension (PH) is highly prevalent in patients with left heart disease (LHD) and negatively impacts prognosis. The most common causes of PH associated with LHD (PH-LHD) are left heart failure and valvular heart disease. In LHD, passive backward transmission of increased left-sided filling pressures leads to isolated post-capillary PH. Additional pulmonary vasoconstriction and remodelling lead to a higher vascular load and combined pre- and post-capillary PH. The increased afterload leads to right ventricular dysfunction and failure. Multimodality imaging of the heart plays a central role in the diagnostic work-up and follow-up of patients with PH-LHD. Echocardiography provides information about the estimated pulmonary artery pressure, morphology and function of the left and right side of the heart, and valvular abnormalities. Cardiac magnetic resonance imaging is the gold standard for volumetric measurements and provides myocardial tissue characterisation. Computed tomography of the thorax may show general features of PH and/or LHD and is helpful in excluding other PH causes. Histopathology reveals a spectrum of pre- and post-capillary vasculopathy, including intimal fibrosis, media smooth muscle cell hyperplasia, adventitial fibrosis and capillary congestion. In this paper, we provide an overview of clinical, imaging and histopathological findings in PH-LHD based on three clinical cases.

[1]  M. Götte,et al.  The role and implications of left atrial fibrosis in surgical mitral valve repair as assessed by CMR: the ALIVE study design and rationale , 2023, Frontiers in Cardiovascular Medicine.

[2]  B. Borlaug,et al.  Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement. , 2023, Journal of the American College of Cardiology.

[3]  D. Playford,et al.  Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes , 2023, Heart.

[4]  D. Playford,et al.  Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes , 2023, Heart.

[5]  F. Eisenhaber,et al.  Diagnostic accuracy of the electrocardiogram for heart failure with reduced or preserved ejection fraction. , 2023, Journal of cardiac failure.

[6]  D. Burkhoff,et al.  Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction , 2023, European journal of heart failure.

[7]  P. Kellman,et al.  Cardiovascular magnetic resonance phenotyping of heart failure with mildly reduced ejection fraction , 2022, European heart journal. Cardiovascular Imaging.

[8]  N. Brunetti,et al.  Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension , 2022, ERJ Open Research.

[9]  Jeroen J. Bax,et al.  Valvular heart disease: shifting the focus to the myocardium , 2022, European heart journal.

[10]  M. Humbert,et al.  2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, European heart journal.

[11]  G. Beck,et al.  Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease. , 2022, Journal of the American College of Cardiology.

[12]  R. Carter,et al.  Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea. , 2022, JAMA cardiology.

[13]  Sanjiv J. Shah,et al.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease , 2022, Circulation research.

[14]  A. van Rossum,et al.  The Value of Passive Leg Raise During Right Heart Catheterization in Diagnosing Heart Failure With Preserved Ejection Fraction , 2022, Circulation. Heart failure.

[15]  Andrew J. Sauer,et al.  Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management , 2022, Heart.

[16]  J. Marcus,et al.  Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload , 2021, Circulation. Heart failure.

[17]  P. Jakuška,et al.  The association of left ventricular histologically verified myocardial fibrosis with pulmonary hypertension in severe aortic stenosis , 2021, Perfusion.

[18]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[19]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[20]  R. Steeds,et al.  Reverse Myocardial Remodeling Following Valve Repair in Patients With Chronic Severe Primary Degenerative Mitral Regurgitation. , 2021, JACC. Cardiovascular imaging.

[21]  M. Markl,et al.  Cine MRI characterizes HFpEF and HFrEF in post-capillary pulmonary hypertension. , 2021, European journal of radiology.

[22]  T. Nagai,et al.  Presence and relevance of mid-systolic notching on right ventricular outflow tract flow velocity envelopes in pulmonary hypertension due to heart failure. , 2020, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  L. Harbaum,et al.  Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  M. Obokata,et al.  Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.

[25]  Mario J. Garcia,et al.  State of the Art: Imaging for Myocardial Viability: A Scientific Statement From the American Heart Association. , 2020, Circulation. Cardiovascular imaging.

[26]  J. Cavalcante,et al.  Impact of Combined Pre and Postcapillary Pulmonary Hypertension on Survival after Transcatheter Aortic Valve Implantation. , 2020, The American journal of cardiology.

[27]  F. Rutten,et al.  Epidemiology of heart failure , 2020, European journal of heart failure.

[28]  S. Solomon,et al.  Interactions between left ventricular ejection fraction, sex and effect of neurohumoral modulators in heart failure , 2020, European journal of heart failure.

[29]  Brandon C. Benefield,et al.  Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension , 2020, ESC heart failure.

[30]  G. Simonneau,et al.  The revised definition of pulmonary hypertension: exploring the impact on patient management , 2019, European heart journal supplements : journal of the European Society of Cardiology.

[31]  P. Lancellotti,et al.  Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension , 2019, Current Cardiology Reports.

[32]  M. Salerno,et al.  Myocardial T1 and ECV Measurement: Underlying Concepts and Technical Considerations. , 2019, JACC. Cardiovascular imaging.

[33]  J. Barberà,et al.  Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  Erwan Donal,et al.  How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). , 2019, European heart journal.

[35]  M. Ghigna,et al.  Pulmonary vascular disease and pulmonary hypertension , 2019, Diagnostic Histopathology.

[36]  Erwan Donal,et al.  Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[37]  D. Celermajer,et al.  Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysis. , 2018, International journal of cardiology.

[38]  M. Taramasso,et al.  Haemodynamic mechanisms and long‐term prognostic impact of pulmonary hypertension in patients with severe aortic stenosis undergoing valve replacement , 2018, European journal of heart failure.

[39]  R. Carter,et al.  A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction , 2018, Circulation.

[40]  J. Wild,et al.  Identifying At-Risk Patients with Combined Pre- and Postcapillary Pulmonary Hypertension Using Interventricular Septal Angle at Cardiac MRI , 2018, Radiology.

[41]  E. V. van Beek,et al.  Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis , 2018, Circulation. Cardiovascular imaging.

[42]  F. Maisano,et al.  Pulmonary Hypertension in Aortic and Mitral Valve Disease , 2018, Front. Cardiovasc. Med..

[43]  A. Voors,et al.  Right ventricular-vascular coupling in heart failure with preserved ejection fraction and pre- vs. post-capillary pulmonary hypertension , 2018, European heart journal cardiovascular Imaging.

[44]  M. Gladwin,et al.  Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction , 2018, JAMA cardiology.

[45]  W. Edwards,et al.  Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction , 2017, Circulation.

[46]  L. Ling,et al.  Right ventricular dysfunction in left‐sided heart failure with preserved versus reduced ejection fraction , 2017, European journal of heart failure.

[47]  G. Weisz,et al.  Pulmonary Hypertension with Left Heart Disease: Prevalence, Temporal Shifts in Etiologies and Outcome. , 2017, The American journal of medicine.

[48]  Richard B. Thompson,et al.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.

[49]  R. Naeije,et al.  The overloaded right heart and ventricular interdependence , 2017, Cardiovascular research.

[50]  A. Masri,et al.  Outcomes of persistent pulmonary hypertension following transcatheter aortic valve replacement , 2017, Heart.

[51]  T. Welte,et al.  More on idiopathic pulmonary arterial hypertension with a low diffusing capacity , 2017, European Respiratory Journal.

[52]  M. Guazzi,et al.  Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction , 2017, European journal of heart failure.

[53]  M. Guazzi,et al.  Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives. , 2017, Journal of the American College of Cardiology.

[54]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.

[55]  S. Plein,et al.  Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review , 2016, Journal of Cardiovascular Magnetic Resonance.

[56]  G. Lip,et al.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[57]  S. Rosenkranz,et al.  Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum. , 2016, Journal of the American College of Cardiology.

[58]  T. Mihaljevic,et al.  Effect of Pulmonary Vascular Pressures on Long-Term Outcome in Patients With Primary Mitral Regurgitation. , 2016, Journal of the American College of Cardiology.

[59]  R. Pai,et al.  Survival in Patients with Degenerative Mitral Stenosis: Results from a Large Retrospective Cohort Study. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[60]  M. Humbert,et al.  A global view of pulmonary hypertension. , 2016, The Lancet. Respiratory medicine.

[61]  R. Ristl,et al.  The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics , 2016, European journal of heart failure.

[62]  R. Wachter,et al.  Left ventricular heart failure and pulmonary hypertension , 2015, European heart journal.

[63]  D. Corrado,et al.  Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death , 2015, Circulation.

[64]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[65]  Shunichi Homma,et al.  Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community‐based cohort , 2014, European journal of heart failure.

[66]  J. Wild,et al.  LGE patterns in pulmonary hypertension do not impact overall mortality. , 2014, JACC. Cardiovascular imaging.

[67]  V. Nkomo,et al.  Prognostic impact of pulmonary artery systolic pressure in patients undergoing transcatheter aortic valve replacement for aortic stenosis. , 2014, The American journal of cardiology.

[68]  E. Nagel,et al.  Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. , 2014, Journal of the American College of Cardiology.

[69]  G. Nickenig,et al.  Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[70]  W. Kuebler,et al.  Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[71]  Tevfik F Ismail,et al.  The Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Nonischemic Dilated Cardiomyopathy , 2013, Circulation.

[72]  S. Rosenkranz,et al.  Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. , 2013, International journal of cardiology.

[73]  N. Westerhof,et al.  Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses , 2013, European Respiratory Journal.

[74]  J. Zamorano,et al.  Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. , 2013, European heart journal cardiovascular Imaging.

[75]  M. Enriquez-Sarano,et al.  Right Ventricular Systolic Function in Organic Mitral Regurgitation: Impact of Biventricular Impairment , 2013, Circulation.

[76]  M. Cameli,et al.  Right ventricular longitudinal strain and right ventricular stroke work index in patients with severe heart failure: left ventricular assist device suitability for transplant candidates. , 2012, Transplantation proceedings.

[77]  Amit R. Patel,et al.  Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension , 2012, Journal of Cardiovascular Magnetic Resonance.

[78]  V. Roger,et al.  Pulmonary pressures and death in heart failure: a community study. , 2012, Journal of the American College of Cardiology.

[79]  James O. Mudd,et al.  Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading , 2012, Circulation.

[80]  B. Griffith,et al.  Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. , 2011, The Journal of thoracic and cardiovascular surgery.

[81]  Victor Mor-Avi,et al.  Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[82]  M. Enriquez-Sarano,et al.  Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. , 2011, European heart journal.

[83]  V. Ferrari,et al.  Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. , 2011, American journal of respiratory and critical care medicine.

[84]  R. Arena,et al.  Pulmonary hypertension with left-sided heart disease , 2010, Nature Reviews Cardiology.

[85]  C. Bauters,et al.  Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation , 2010, Heart.

[86]  L. Pierard,et al.  Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation , 2010, Circulation.

[87]  G. Raskob,et al.  Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. , 2010, Chest.

[88]  G. Filippatos,et al.  Effects of Right Ventricular Ejection Fraction on Outcomes in Chronic Systolic Heart Failure , 2010, Circulation.

[89]  P. Varadarajan,et al.  Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension. , 2009, The Annals of thoracic surgery.

[90]  A. Haque,et al.  Pulmonary and cardiovascular complications of obesity: an autopsy study of 76 obese subjects. , 2008, Archives of pathology & laboratory medicine.

[91]  R. Bansal,et al.  Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. , 2007, The Annals of thoracic surgery.

[92]  R. Kwong,et al.  Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. , 2007, Journal of the American College of Cardiology.

[93]  F. López-Ríos,et al.  Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure , 2005, European journal of heart failure.

[94]  R. Mohiaddin,et al.  Applications of phase-contrast flow and velocity imaging in cardiovascular MRI , 2005, European Radiology.

[95]  Warren J Manning,et al.  Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[96]  Robert R Edelman,et al.  Contrast-enhanced MR imaging of the heart: overview of the literature. , 2004, Radiology.

[97]  M. Enriquez-Sarano,et al.  Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. , 2002, Journal of the American College of Cardiology.

[98]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[99]  J. Tomashefski,et al.  Cardiopulmonary pathology in patients with sleep apnea/obesity hypoventilation syndrome. , 1997, Human pathology.

[100]  J. West,et al.  Vulnerability of pulmonary capillaries in heart disease. , 1995, Circulation.

[101]  D. Moodie,et al.  Primary pulmonary hypertension, then and now: 28 years of experience. , 1992, Cleveland Clinic journal of medicine.

[102]  C. Wagenvoort Morphological substrate for the reversibility and irreversibility of pulmonary hypertension. , 1988, European heart journal.

[103]  C. Wagenvoort Lung biopsy specimens in the evaluation of pulmonary vascular disease. , 1980, Chest.

[104]  H. Tandon,et al.  Pulmonary vascular changes associated with isolated mitral stenosis in India. , 1975, British heart journal.

[105]  E. W. Hancock,et al.  Regression of extreme pulmonary hypertension after mitral valve surgery. , 1972, The American journal of cardiology.

[106]  W. Evans,et al.  PULMONARY HYPERTENSION IN MITRAL STENOSIS , 1957, British heart journal.

[107]  G. Myers,et al.  Correlation of pulmonary arteriolar resistance with pulmonary vascular changes in patients with mitral stenosis before and after valvulotomy. , 1955, The New England journal of medicine.

[108]  A. Rigby,et al.  Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials , 2018, European heart journal.

[109]  J. Zamorano,et al.  Four chamber right ventricular longitudinal strain versus right free wall longitudinal strain. Prognostic value in patients with left heart disease. , 2016, Cardiology journal.

[110]  P. Sengupta,et al.  Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. , 2015, JACC. Cardiovascular imaging.

[111]  G. Pedrizzetti,et al.  Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. , 2015, European heart journal cardiovascular Imaging.